Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DD… Read more
Creative Medical Technology Holdings Inc (CELZ) - Total Assets
Latest total assets as of September 2025: $5.85 Million USD
Based on the latest financial reports, Creative Medical Technology Holdings Inc (CELZ) holds total assets worth $5.85 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Creative Medical Technology Holdings Inc - Total Assets Trend (2006–2024)
This chart illustrates how Creative Medical Technology Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Creative Medical Technology Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Creative Medical Technology Holdings Inc's total assets of $5.85 Million consist of 92.0% current assets and 8.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 89.1% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $2.19K | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $530.56K | 8.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2024)
This chart illustrates how Creative Medical Technology Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Creative Medical Technology Holdings Inc's current assets represent 92.0% of total assets in 2024, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 89.1% of total assets in 2024, up from 0.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is intangible assets at 8.0% of total assets.
Creative Medical Technology Holdings Inc Competitors by Total Assets
Key competitors of Creative Medical Technology Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Creative Medical Technology Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Creative Medical Technology Holdings Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Creative Medical Technology Holdings Inc is currently not profitable relative to its asset base.
Creative Medical Technology Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 20.71 | 19.13 | 0.00 |
| Quick Ratio | 20.70 | 19.12 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.15 Million | $ 6.00 Million | $ -40.42 Million |
Creative Medical Technology Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Creative Medical Technology Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.21 |
| Latest Market Cap to Assets Ratio | 0.67 |
| Asset Growth Rate (YoY) | -37.8% |
| Total Assets | $6.67 Million |
| Market Capitalization | $4.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Creative Medical Technology Holdings Inc's assets below their book value (0.67 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Creative Medical Technology Holdings Inc's assets decreased by 37.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Creative Medical Technology Holdings Inc (2006–2024)
The table below shows the annual total assets of Creative Medical Technology Holdings Inc from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $6.67 Million | -37.76% |
| 2023-12-31 | $10.72 Million | -44.15% |
| 2022-12-31 | $19.19 Million | +70.27% |
| 2021-12-31 | $11.27 Million | +1469.88% |
| 2020-12-31 | $717.77K | +35.22% |
| 2019-12-31 | $530.80K | +11.24% |
| 2018-12-31 | $477.16K | +134.88% |
| 2017-12-31 | $203.15K | -37.01% |
| 2016-12-31 | $322.51K | +149211.11% |
| 2015-12-31 | $216.00 | -77.36% |
| 2014-12-31 | $954.00 | +155.08% |
| 2013-12-31 | $374.00 | -76.15% |
| 2012-12-31 | $1.57K | -49.50% |
| 2011-12-31 | $3.10K | +650.00% |
| 2010-12-31 | $414.00 | -86.54% |
| 2009-12-31 | $3.08K | +104.73% |
| 2008-12-31 | $1.50K | -95.78% |
| 2007-12-31 | $35.63K | +21.45% |
| 2006-12-31 | $29.34K | -- |